Clinical trials
Recruiting Cholangiocarcinoma trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
10 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 2 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 10 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Erasmus Medical Center | 2 |
| Alentis Therapeutics AG | 1 |
| Amsterdam UMC, location VUmc | 1 |
| Eli Lilly and Company | 1 |
| Fore Biotherapeutics | 1 |
| Maastricht University | 1 |
| Maastricht University Medical Center | 1 |
| Mara Veenstra, MD | 1 |
| Memorial Sloan Kettering Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cholangiocarcinoma | 10 |
| Carcinoma, Hepatocellular | 3 |
| Klatskin Tumor | 3 |
| Biliary Tract Neoplasms | 2 |
| Breast Neoplasms | 2 |
| Colorectal Neoplasms | 2 |
| Ovarian Neoplasms | 2 |
| Carcinoma, Transitional Cell | 1 |
| Common Bile Duct Neoplasms | 1 |
| Esophageal Neoplasms | 1 |
Trials
Showing 1 to 10 of 10. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.